Developing An Inter-ministerial Substance Use Response Strategy For Lebanon: Process, Content And Le

Developing an inter-ministerial substance use response strategy for Lebanon: process, content and lessons learned

This article indicates that evidence on substance use in Lebanon shows an increase in usage, limited availability and accessibility to evidence-based services, and high level of stigma and discrimination. In line with the “Mental Health and Substance Use Strategy for Lebanon 2015–2020”, the Ministry of Public Health initiated the process of developing a strategy focused on substance use response to address these challenges in collaboration with the Ministries of Education and Higher Education, Interior and Municipalities, Justice and Social Affairs. The result of this process was a strategy launched jointly by the ministries including six domains of action covering the whole spectrum of substance use response with strategic objectives addressing the identified challenges.

Download Developing an inter-ministerial substance use response strategy for Lebanon: process, content and lessons learned

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R01AD09	TABUNEX	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
C09CA03	TABUVAN	G	Valsartan - 80mg	80mg	Tablet, film coated	387,027 L.L
C09CA03	TABUVAN	G	Valsartan - 160mg	160mg	Tablet, film coated	544,256 L.L
C02CA06	TACHYBEN	G	Urapidil - 25mg/5ml	25mg/5ml	Injectable solution	1,439,255 L.L
L04AD02	TACROGRAF 0.5	G	Tacrolimus - 0.5mg	0.5mg	Capsule	7,004,024 L.L
L04AD02	TACROGRAF 1	G	Tacrolimus - 1mg	1mg	Capsule	12,679,940 L.L
L04AD02	TACROGRAF 5	G	Tacrolimus - 5mg	5mg	Capsule	67,507,154 L.L
D11AH01	TACRUS	G	Tacrolimus monohydrate - 0.1%	0.1%	Ointment	1,857,190 L.L
G04BE08	TADALAFIL BIOGARAN	G	Tadalafil - 5mg	5mg	Tablet, coated	3,369,013 L.L
G04BE08	TADALAFIL BIOGARAN	G	Tadalafil - 10mg	10mg	Tablet, coated	1,397,596 L.L
G04BE08	TADALAGEN	G	Tadalafil - 20mg	20mg	Tablet, film coated	1,032,839 L.L
G04BE08	TADALAGEN	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,766,193 L.L
G04BE08	TADAPRESS	G	Tadalafil - 20mg	20mg	Tablet, film coated	13,621,308 L.L
G04BE08	TADILAS	G	Tadalafil - 20mg	20mg	Tablet, film coated	607,417 L.L
G04BE08	TADILAS	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,583,046 L.L
P02DA01	TAENIASAN	G	Niclosamide - 500mg	500mg	Tablet	94,709 L.L
S01EE05	TAFLUPRO	G	Tafluprost - 0.0015%	0.0015%	Solution	1,912,288 L.L
J01AA12	TAGIX	G	Tigecycline - 50mg	50mg	Injectable lyophilised powder for solution	2,436,386 L.L
L01EB04	TAGRISSO	B	Osimertinib - 80mg	80mg	Tablet, film coated	L.L
L01EB04	TAGRISSO	B	Osimertinib - 80mg	80mg	Tablet, film coated	603,192,941 L.L
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml	300mg	Injectable solution	L.L
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml	300mg	Injectable solution	1,202,366,121 L.L
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml		Injectable solution	1,204,227,927 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	85,080,792 L.L
G04CA02	TALUSIN	G	Tamsulosin HCl - 0.4mg	0.4mg	Capsule, modified release	683,440 L.L
L01FX29	TALVEY	B	Talquetamab - 2mg/ml	3mg/1.5ml	Injectable solution	45,594,403 L.L
L01FX29	TALVEY	B	Talquetamab - 40mg/ml	40mg/ml	Injectable solution	555,916,745 L.L
G04BE08	TALYS	G	Tadalafil - 20mg	20mg	Tablet, film coated	1,032,839 L.L
G04BE08	TALYS	G	Tadalafil - 20mg	20mg	Tablet, film coated	275,680 L.L
G04BE08	TALYS	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,574,216 L.L

...